维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Steger GG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Predictive factors for a complete pathological response in primary breast cancer treated neoadjuvantly with epirubicin/taxane+G-CSF regimen显示文摘	Steger GG Wenzel C Schmidinger M	2001	Proc Am Soc Clin Oncol2001，20，39：	1
2	Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro显示文摘	Links-Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
3	VHER2-positive breast cancer:a new piece of the puzzle显示文摘	Gnant M Bartsch R Steger GG	2014	Lancet Oncol2014，15，66：	1
4	HER2-positive breast cancer: a new piece of the puzzle显示文摘	GNANT M BARTSCH R STEGER GG	2014	Lancet Oncol2014，15，：	1
5	The potential risk of neoadjuvant chemotherapy in breast cancer patients- -results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07) 显示文摘	Taucher S Steger GG Jakesz R	2008	Breast Cancer Res Treat2008，112，2：	1
6	Trends and novel approaches in neoadjuvant treatment of breast cancer显示文摘	Steger GG Bartsch R	2011	Breast Care (Basel)2011，6，6：	1
7	The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the austrian breast and eoloreetal eaneer study group (ABCSG-07) 显示文摘	Taucher S Steger GG Jakesz R	2008	Breast Cancer Res Treat2008，112，2：	1
8	Activity of fulvestrant in HER2-overexpressing advanced breast cancer 显示文摘	Robertson JF Steger GG Neven P	2010	Ann Oncol2010，21，6：	1
9	Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses 显示文摘	Steger GG Wrba F Mader R	1991	Eur J Cancer1991，27，：	1
10	Pathologic complete response with six compared with three cycles of neoadju- vant epirubicin plus docetaxel and granulocyte colony- stimulating factor in operable breast cancer:Results of ABCSG-14显示文摘	Steger GG Galid A Gnant M	2007	Journal of Clinical Oncology2007，25，15：	1
11	Trends and novel approaches inneoadjuvant treatment of breast cancer显示文摘	Steger GG Bartsch R	2011	Breast Care (Basel)2011，6，6：	1
12	Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases显示文摘	Lipton A Steger GG Figueroa J		0，，：	1
13	Randomized active-controlled phase Ⅱ study of denosumab efficacy and safety in patients with breast cancer-related bone metastases 显示文摘	Lipton A Steger GG Figueroa J	2007	J Clin Oncol2007，25，28：	1
14	Pathologic complete reponse with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: result of ABCSG-14 显示文摘	Steger GG Galid A Gnant M	2007	J Clin Oncol2007，25，15：	1
15	Pilot-trial of trustuzumab + weekly epidoxorubicin/docetaxel in the neoadjuvant treatment of primary breast cancer-pretiminary results显示文摘	Steger GG Wenzel C Locker GJ	2002	Proc Am Soc Clin Oncol2002，21，：	1
16	Angiogenic effect of naive and5fluorouracil resistant colon carcinoma on endothelial cells in vitro显示文摘	Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
17	Angiogenic effect of naive and 5-fiuorouracil resistant colon carcinoma on endothelial cells in vitro 显示文摘	Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
18	Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy显示文摘	Lipton A Steger GG Figueroa J	2008	Clin Cancer Res2008，14，20：	1
19	Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus doeetaxel and granulocyte colony-stimulating factor in operable breast cancer:results of ABCSG-14显示文摘	Steger GG Galid A Gnant M at al	2007	J Clin Oncol2007，25，15：	1
20	Randomized active- controlled phase II study of denosumab efficacy and safety in patients With breast cancer-related bone metastases显示文摘	Lipton A Steger GG Figueroa J	2007	J Clin Oncol2007，25，28：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示